In line with the aforementioned RIPK2 mRNA findings (Fig. 1b, g), the RIPK2-induced activity scores are positively—whereas the RIPK2-repressed activity scores are negatively—associated with PC progression and aggressiveness in both cohorts (Supplementary Fig. 13). The gene discussed is RIPK2; the disease is pachyonychia congenita.